Literature DB >> 3605310

Toxic effects of recombinant tumor necrosis factor in suckling mice. Comparisons with interferon alpha/beta.

I Gresser, D Woodrow, J Moss, C Maury, J Tavernier, W Fiers.   

Abstract

Newborn Swiss and A2G mice were given daily subcutaneous injections for 1 week of highly purified recombinant mouse tumor necrosis factor (TNF) or mouse interferon alpha/beta. Both treatments resulted in inhibition of growth of suckling mice and severe fatty changes and necrosis in the liver. The simultaneous injection of polyclonal antibody to interferon alpha/beta abrogated the effects of interferon but did not block the effects induced by TNF. The kidneys of TNF-treated suckling mice could be distinguished from interferon-treated mice by the absence of glomerular basement membrane abnormalities and the presence of numerous rounded eosinophilic hyaline granules within the cytoplasm of the proximal tubules. Treatment of suckling mice with TNF and interferon alpha/beta induced similar changes in the spleen and thymus. Interferon treatment of suckling A2G mice resulted in the appearance of pulmonary cysts, which were not observed in TNF-treated mice. It is concluded that the pattern of lesions induced in suckling mice by mouse TNF is both similar and different from that induced by mouse interferon alpha/beta.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3605310      PMCID: PMC1899801     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  17 in total

1.  An ultrastructural study of the development of nephritis in mice treated with interferon in the neonatal period.

Authors:  L Morel-Maroger; J C Sloper; J Vinter; D Woodrow; I Gresser
Journal:  Lab Invest       Date:  1978-11       Impact factor: 5.662

Review 2.  Interferon treatment of human neoplasia.

Authors:  H Strander
Journal:  Adv Cancer Res       Date:  1986       Impact factor: 6.242

Review 3.  Can interferon induce disease?

Authors:  I Gresser
Journal:  Interferon       Date:  1982

4.  Electrophoretically pure mouse interferon inhibits growth, induces liver and kidney lesions, and kills suckling mice.

Authors:  I Gresser; M Aguet; L Morel-Maroger; D Woodrow; F Puvion-Dutilleul; J C Guillon; C Maury
Journal:  Am J Pathol       Date:  1981-03       Impact factor: 4.307

5.  Interferon alters the composition and metabolism of lipids in the liver of suckling mice.

Authors:  G Zwingelstein; R Meister; N A Malak; C Maury; I Gresser
Journal:  J Interferon Res       Date:  1985

6.  Interferon as a cause of endoplasmic reticulum abnormalities within hepatocytes in newborn mice.

Authors:  J Moss; D F Woodrow; J C Sloper; Y Rivière; J C Guillon; I Gresser
Journal:  Br J Exp Pathol       Date:  1982-02

7.  Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. V. Comparisons with the action of tumor necrosis factor.

Authors:  I Gresser; F Belardelli; J Tavernier; W Fiers; F Podo; M Federico; G Carpinelli; P Duvillard; M Prade; C Maury
Journal:  Int J Cancer       Date:  1986-11-15       Impact factor: 7.396

8.  Interferon induces pulmonary cysts in A2G mice.

Authors:  D Woodrow; J Moss; I Gresser
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

9.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection.

Authors:  I Gresser; M G Tovey; M E Bandu; C Maury; D Brouty-Boyé
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

10.  Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.

Authors:  B Beutler; J Mahoney; N Le Trang; P Pekala; A Cerami
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  12 in total

1.  Tumor necrosis factor induces glomerular damage in the rabbit.

Authors:  T Bertani; M Abbate; C Zoja; D Corna; N Perico; P Ghezzi; G Remuzzi
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

Review 2.  Hepatic fibrosis--current concepts of pathogenesis and therapy.

Authors:  B Högemann; W Domschke
Journal:  Gastroenterol Jpn       Date:  1993-08

Review 3.  Expression of the genes of interferons and other cytokines in normal and diseased tissues of man.

Authors:  M G Tovey
Journal:  Experientia       Date:  1989-06-15

4.  Infection of neonatal mice with sindbis virus results in a systemic inflammatory response syndrome.

Authors:  W B Klimstra; K D Ryman; K A Bernard; K B Nguyen; C A Biron; R E Johnston
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways.

Authors:  L G Guidotti; S Guilhot; F V Chisari
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 6.  TNF superfamily: a growing saga of kidney injury modulators.

Authors:  Maria D Sanchez-Niño; Alberto Benito-Martin; Sara Gonçalves; Ana B Sanz; Alvaro C Ucero; Maria C Izquierdo; Adrian M Ramos; Sergio Berzal; Rafael Selgas; Marta Ruiz-Ortega; Jesus Egido; Alberto Ortiz
Journal:  Mediators Inflamm       Date:  2010-10-04       Impact factor: 4.711

Review 7.  Interleukins. Clinical pharmacokinetics and practical implications.

Authors:  V Bocci
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

Review 8.  Immunomodulation of transplant rejection using monoclonal antibodies and soluble receptors.

Authors:  M L Alegre; D J Lenschow; J A Bluestone
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

9.  High tumor necrosis factor alpha (TNF-alpha) production in Trypanosoma cruzi-infected pregnant mice and increased TNF-alpha gene transcription in their offspring.

Authors:  M T Rivera; S Marques de Araujo; R Lucas; J Deman; C Truyens; M P Defresne; P de Baetselier; Y Carlier
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

10.  Exacerbation of toxic effects by endotoxin contamination of recombinant human tumor necrosis factor.

Authors:  Y Ozaki; T Oyama; S Kume
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.